On January 6, Juneyao Grand Healthy Drinks Co.Ltd(605388) ( Juneyao Grand Healthy Drinks Co.Ltd(605388) , 605388) issued an announcement on abnormal fluctuations in stock trading.
According to the announcement, Juneyao Grand Healthy Drinks Co.Ltd(605388) stock prices deviated from the daily closing price by more than 20% in three consecutive trading days on January 4, 5 and 6, 2022. According to the relevant provisions of Shanghai Stock Exchange, it belongs to abnormal fluctuation of stock trading. According to the self-examination of the company’s board of directors and a letter of inquiry to the controlling shareholders and actual controllers, as of the disclosure date of this announcement, there is no material information that should be disclosed but not disclosed. As of the closing on January 6, 2022, the rolling P / E ratio of the company’s shares on January 6, 2022 was 59.41 times, higher than the average level of the same industry.
Juneyao Grand Healthy Drinks Co.Ltd(605388) said in the announcement that the company’s main business is still lactic acid bacteria drinks, and the company’s chewing tablets, drinks and other products related to Helicobacter pylori are still in the product investment stage. As of the first three quarters of 2021, the revenue of the above products accounted for less than 5% of the company’s operating revenue (this data is Unaudited), which has little impact on the company’s operating performance.
In the first three quarters of 2021, Juneyao Grand Healthy Drinks Co.Ltd(605388) achieved an operating revenue of 700.3999 million yuan, a year-on-year decrease of 1.36%; The net profit attributable to the shareholders of the listed company was RMB 144.0135 million, a year-on-year decrease of 27.04%; The net profit attributable to the shareholders of the listed company after deducting non recurring profits and losses was 104.3611 million yuan, a year-on-year decrease of 35.55%.
As of the closing on the 6th, Juneyao Grand Healthy Drinks Co.Ltd(605388) rose by the limit, with a closing price of 22.17 yuan / share and a total market value of 9.533 billion yuan.
In terms of news, recently, the U.S. Department of health and human services released the 15th edition of carcinogen report, in which 8 new carcinogens, including Helicobacter pylori chronic infection, were listed as clear carcinogens. Or affected by this news, Helicobacter pylori concept stocks continued to rise. In addition to the Juneyao Grand Healthy Drinks Co.Ltd(605388) limit, Beijing Scitop Bio-Tech Co.Ltd(300858) (300858), Zhejiang Yatai Pharmaceutical Co.Ltd(002370) (002370) all rose, and Shanshui Technology (301190) followed.
(surging News)
